Ian Bridges

Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study

2023 | Lékařská fakulta v Plzni, Lékařská fakulta v Hradci Králové

Publikace